Follow
Annabeth P. Groenman
Annabeth P. Groenman
Unknown affiliation
Verified email at uva.nl
Title
Cited by
Cited by
Year
Childhood Psychiatric Disorders as Risk Factor for Subsequent Substance Abuse: A Meta-Analysis
AP Groenman, TWP Janssen, J Oosterlaan
Journal of the American Academy of Child & Adolescent Psychiatry, 2017
3412017
Substance use disorders in adolescents with attention deficit hyperactivity disorder: A 4‐year follow‐up study
AP Groenman, J Oosterlaan, N Rommelse, B Franke, H Roeyers, ...
Addiction 108 (8), 1503-1511, 2013
1982013
The NeuroIMAGE study: a prospective phenotypic, cognitive, genetic and MRI study in children with attention-deficit/hyperactivity disorder. Design and descriptives
D von Rhein, M Mennes, H van Ewijk, AP Groenman, MP Zwiers, ...
European child & adolescent psychiatry 24, 265-281, 2015
1792015
A 6-year follow-up of a large European cohort of children with attention-deficit/hyperactivity disorder-combined subtype: outcomes in late adolescence and young adulthood
M van Lieshout, M Luman, JWR Twisk, H van Ewijk, AP Groenman, ...
European child & adolescent psychiatry 25, 1007-1017, 2016
1422016
Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder
AP Groenman, J Oosterlaan, NNJ Rommelse, B Franke, CU Greven, ...
The British Journal of Psychiatry 203 (2), 112-119, 2013
1042013
An update on the safety of psychostimulants for the treatment of attention-deficit/hyperactivity disorder
AP Groenman, LJS Schweren, A Dietrich, PJ Hoekstra
Expert opinion on drug safety 16 (4), 455-464, 2017
622017
Meta-analysis: which components of parent training work for children with attention-deficit/hyperactivity disorder?
TJ Dekkers, R Hornstra, S van Der Oord, M Luman, PJ Hoekstra, ...
Journal of the American Academy of Child & Adolescent Psychiatry 61 (4), 478-494, 2022
572022
International consensus statement for the screening, diagnosis, and treatment of adolescents with concurrent attention-deficit/hyperactivity disorder and substance use disorder
H Özgen, R Spijkerman, M Noack, M Holtmann, ASA Schellekens, ...
European addiction research 26 (4-5), 223-232, 2020
432020
Stimulant treatment profiles predicting co-occurring substance use disorders in individuals with attention-deficit/hyperactivity disorder
AP Groenman, LJS Schweren, W Weeda, M Luman, SDS Noordermeer, ...
European child & adolescent psychiatry 28, 1213-1222, 2019
392019
Substance use and nicotine dependence in persistent, remittent, and late-onset ADHD: a 10-year longitudinal study from childhood to young adulthood
S Ilbegi, AP Groenman, A Schellekens, CA Hartman, PJ Hoekstra, ...
Journal of neurodevelopmental disorders 10, 1-8, 2018
382018
An individual participant data meta-analysis: behavioral treatments for children and adolescents with attention-deficit/hyperactivity disorder
AP Groenman, R Hornstra, PJ Hoekstra, L Steenhuis, A Aghebati, ...
Journal of the American Academy of Child & Adolescent Psychiatry 61 (2), 144-158, 2022
342022
Dopamine and serotonin genetic risk scores predicting substance and nicotine use in attention deficit/hyperactivity disorder
AP Groenman, CU Greven, MMJ Van Donkelaar, A Schellekens, ...
Addiction biology 21 (4), 915-923, 2016
282016
Smoking and the developing brain: altered white matter microstructure in attention‐deficit/hyperactivity disorder and healthy controls
H van Ewijk*, AP Groenman*, MP Zwiers, DJ Heslenfeld, SV Faraone, ...
Human Brain Mapping 36 (3), 1180-1189, 2015
282015
Neurocognitive predictors of substance use disorders and nicotine dependence in ADHD probands, their unaffected siblings, and controls: a 4‐year prospective follow‐up
AP Groenman, J Oosterlaan, CU Greven, PJ Vuijk, N Rommelse, ...
Journal of Child Psychology and Psychiatry 56 (5), 521-529, 2015
262015
Ageing and heterogeneity regarding autism spectrum conditions: A protocol paper of an accelerated longitudinal study
HM Geurts, JAA van Rentergem, T Radhoe, C Torenvliet, ...
BMJ open 11 (3), e040943, 2021
242021
Parallel age‐related cognitive effects in autism: A cross‐sectional replication study
C Torenvliet, AP Groenman, TA Radhoe, JA Agelink van Rentergem, ...
Autism Research 15 (3), 507-518, 2022
202022
Menstruation and menopause in autistic adults: Periods of importance?
AP Groenman, C Torenvliet, TA Radhoe, JA Agelink van Rentergem, ...
Autism 26 (6), 1563-1572, 2022
182022
Non‐pharmacological interventions for challenging behaviours of adults with intellectual disabilities: A meta‐analysis
E Bruinsma, BJ Van Den Hoofdakker, AP Groenman, PJ Hoekstra, ...
Journal of Intellectual Disability Research 64 (8), 561-578, 2020
182020
Role of conduct problems in the relation between Attention-Deficit Hyperactivity disorder, substance use, and gaming
GH Schoenmacker, AP Groenman, E Sokolova, J Oosterlaan, ...
European Neuropsychopharmacology 30, 102-113, 2020
182020
Assessing quality of life in psychosocial and mental health disorders in children: a comprehensive overview and appraisal of generic health related quality of life measures
JO Mierau, D Kann-Weedage, PJ Hoekstra, L Spiegelaar, DEMC Jansen, ...
BMC pediatrics 20, 1-16, 2020
172020
The system can't perform the operation now. Try again later.
Articles 1–20